HomeCCCC • NASDAQ
add
C4 Therapeutics Inc
Previous close
$2.16
Day range
$1.95 - $2.16
Year range
$1.95 - $11.17
Market cap
145.06M USD
Avg Volume
1.63M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 5.18M | 58.75% |
Operating expense | 10.37M | 0.74% |
Net income | -34.57M | 0.52% |
Net profit margin | -667.82 | 37.34% |
Earnings per share | -0.49 | 27.94% |
EBITDA | -37.23M | -0.63% |
Effective tax rate | -0.38% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 244.90M | -3.46% |
Total assets | 349.60M | -7.13% |
Total liabilities | 133.62M | 2.52% |
Total equity | 215.99M | — |
Shares outstanding | 70.99M | — |
Price to book | 0.71 | — |
Return on assets | -25.98% | — |
Return on capital | -31.88% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -34.57M | 0.52% |
Cash from operations | -17.93M | 25.31% |
Cash from investing | 13.67M | -57.21% |
Cash from financing | 112.00K | -99.81% |
Net change in cash | -4.15M | -106.33% |
Free cash flow | -8.38M | 43.31% |
About
Founded
2015
Headquarters
Website
Employees
110
